5858619
Last Update Posted: 2026-06-04
Recruiting
All Genders accepted | 18 Years + |
15 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Molecular Signatures of Cutaneous Dupilumab Response
This study examines the effect of IL4RA blockade with dupilumab on the immune cells of atopic dermatitis skin lesions.
This study examines the effect of IL4RA blockade with dupilumab on the immune cells of atopic dermatitis skin lesions.
Eligibility
Relevant conditions:
Atopic Dermatitis
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
Jeffrey Cheng, MD, PhD
rashes@ucsf.edu
415 575 0524
Data sourced from ClinicalTrials.gov